RESPONSE-ADAPTED THERAPY OF DE-NOVO ACUTE MYELOBLASTIC-LEUKEMIA (AML)- UPDATE OF A PHASE-II MULTICENTER STUDY OF SEQUENTIAL INDUCTION REGIMENS IDALUBICIN CYTARABINE AND MITOXANTRONE/ETOPOSIDE/

VANDERJAGT R ROBINSON S GLUCK S BELCH A SHERIDAN D MATTHEWS J LARRATT L MARKMAN S DIPIETRO N PHAM B SHUSTIK C STEWART K

R. Vanderjagt et al., RESPONSE-ADAPTED THERAPY OF DE-NOVO ACUTE MYELOBLASTIC-LEUKEMIA (AML)- UPDATE OF A PHASE-II MULTICENTER STUDY OF SEQUENTIAL INDUCTION REGIMENS IDALUBICIN CYTARABINE AND MITOXANTRONE/ETOPOSIDE/, Blood, 90(10), 1997, pp. 2264-2264

NO

Hematology

Blood → ACNP

00064971

90

10

1997

1

1

2264 - 2264

ISI

0006-4971(1997)90:10<2264:RTODAM>2.0.ZU;2-3